B. Gail Macik

2.6k total citations
32 papers, 1.9k citations indexed

About

B. Gail Macik is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, B. Gail Macik has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in B. Gail Macik's work include Hemophilia Treatment and Research (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). B. Gail Macik is often cited by papers focused on Hemophilia Treatment and Research (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). B. Gail Macik collaborates with scholars based in United States, Italy and Australia. B. Gail Macik's co-authors include Stephen H. Caldwell, Harold R. Roberts, Maureane Hoffman, K. Rajender Reddy, Patrick G. Northup, Armando Tripodi, Arun J. Sanyal, Ton Lisman, Cacilda Casartelli and S. C. Barranco and has published in prestigious journals such as New England Journal of Medicine, Blood and Hepatology.

In The Last Decade

B. Gail Macik

32 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Gail Macik United States 19 947 416 388 307 202 32 1.9k
Anne Riddell United Kingdom 26 871 0.9× 342 0.8× 314 0.8× 261 0.9× 201 1.0× 68 1.7k
Elisabeth Erhardtsen Denmark 21 1.5k 1.6× 318 0.8× 361 0.9× 314 1.0× 190 0.9× 28 2.2k
Erhard Hiller Germany 23 856 0.9× 336 0.8× 131 0.3× 172 0.6× 298 1.5× 96 2.0k
Sabrina Gavasso Italy 30 1.4k 1.4× 327 0.8× 469 1.2× 438 1.4× 333 1.6× 70 2.5k
Annie Bezeaud France 25 726 0.8× 617 1.5× 1.0k 2.7× 736 2.4× 386 1.9× 67 2.5k
Emmanuelle de Raucourt France 17 324 0.3× 328 0.8× 601 1.5× 471 1.5× 214 1.1× 54 1.3k
D. Marchesi Italy 15 324 0.3× 194 0.5× 668 1.7× 424 1.4× 226 1.1× 21 1.7k
Pratima Chowdary United Kingdom 31 2.6k 2.8× 313 0.8× 320 0.8× 286 0.9× 703 3.5× 161 3.7k
Martin R. Schipperus Netherlands 23 1.4k 1.4× 209 0.5× 95 0.2× 99 0.3× 441 2.2× 92 2.1k
Rudolf Pihusch Germany 21 685 0.7× 123 0.3× 120 0.3× 140 0.5× 141 0.7× 43 1.2k

Countries citing papers authored by B. Gail Macik

Since Specialization
Citations

This map shows the geographic impact of B. Gail Macik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gail Macik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gail Macik more than expected).

Fields of papers citing papers by B. Gail Macik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Gail Macik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gail Macik. The network helps show where B. Gail Macik may publish in the future.

Co-authorship network of co-authors of B. Gail Macik

This figure shows the co-authorship network connecting the top 25 collaborators of B. Gail Macik. A scholar is included among the top collaborators of B. Gail Macik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Gail Macik. B. Gail Macik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kunk, Paul R., Jacqueline T. Brown, Melissa McShane, Surabhi Palkimas, & B. Gail Macik. (2016). Direct oral anticoagulants in hypercoagulable states. Journal of Thrombosis and Thrombolysis. 43(1). 79–85. 28 indexed citations
2.
Murphy, Peter, et al.. (2014). Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia. Blood Coagulation & Fibrinolysis. 26(2). 211–213. 7 indexed citations
3.
Balogun, Rasheed A., André A. Kaplan, David M. Ward, et al.. (2010). Clinical applications of therapeutic apheresis. Journal of Clinical Apheresis. 25(5). 250–264. 18 indexed citations
4.
Kuter, David J., Mathias Rummel, Ralph V. Boccia, et al.. (2010). Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia. New England Journal of Medicine. 363(20). 1889–1899. 288 indexed citations
5.
Turba, Ulku C., Bülent Arslan, Saher S. Sabri, et al.. (2009). Günter Tulip Filter Retrieval Experience: Predictors of Successful Retrieval. CardioVascular and Interventional Radiology. 33(4). 732–738. 28 indexed citations
6.
Caldwell, Stephen H., Maureane Hoffman, Ton Lisman, et al.. (2006). Coagulation disorders and hemostasis in liver disease. Hepatology. 44(4). 1039–1046. 352 indexed citations
7.
Macik, B. Gail, et al.. (2006). Hematologic Disorders in Critically Ill Patients. Seminars in Respiratory and Critical Care Medicine. 27(3). 286–296. 9 indexed citations
8.
Shami, Vanessa M., Stephen H. Caldwell, Elizabeth E. Hespenheide, et al.. (2003). Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transplantation. 9(2). 138–143. 155 indexed citations
9.
Macik, B. Gail. (2003). The Future of Anticoagulation Clinics. Journal of Thrombosis and Thrombolysis. 16(1-2). 55–59. 22 indexed citations
10.
Macik, B. Gail, et al.. (2002). Improving the safety profile of warfarin. Seminars in Hematology. 39(3). 179–186. 8 indexed citations
11.
Macik, B. Gail, Jacob H. Rand, & Barbara A. Konkle. (2001). Thrombophilia: What's a Practitioner to Do?. Hematology. 2001(1). 322–338. 8 indexed citations
12.
Macik, B. Gail & P. Crow. (1999). Acquired autoantibodies to coagulation factors. Current Opinion in Hematology. 6(5). 323–328. 10 indexed citations
13.
Ortel, Thomas L., Linda Charles, Frank G. Keller, et al.. (1994). Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. American Journal of Hematology. 45(2). 128–135. 96 indexed citations
14.
Provenzale, James M., E. Ralph Heinz, Thomas L. Ortel, et al.. (1994). Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings.. Radiology. 192(2). 531–537. 27 indexed citations
15.
Hage, Marvin L., et al.. (1994). Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report. Prenatal Diagnosis. 14(9). 873–877. 27 indexed citations
16.
Macik, B. Gail, Celeste Lindley, William T. Sawyer, et al.. (1993). Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa). Blood Coagulation & Fibrinolysis. 4(4). 521–528. 56 indexed citations
17.
Pratt, Charlotte W., B. Gail Macik, & Frank Church. (1989). Protein C inhibitor: Purification and proteinase reactivity. Thrombosis Research. 53(6). 595–602. 24 indexed citations
18.
Macik, B. Gail, et al.. (1989). Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor. Thrombosis Research. 56(5). 603–609. 64 indexed citations
19.
Macik, B. Gail, et al.. (1989). Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor. American Journal of Hematology. 32(3). 232–234. 53 indexed citations
20.
Passannante, Anthony N. & B. Gail Macik. (1988). Case Report: The Heparin Flush Syndrome: A Cause of Iatrogenic Hemorrhage. The American Journal of the Medical Sciences. 296(1). 71–73. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Riddell Breakdown of academic impact, for papers by Elisabeth Erhardtsen Breakdown of academic impact, for papers by Erhard Hiller Breakdown of academic impact, for papers by Sabrina Gavasso Breakdown of academic impact, for papers by Annie Bezeaud Breakdown of academic impact, for papers by Emmanuelle de Raucourt Breakdown of academic impact, for papers by D. Marchesi Breakdown of academic impact, for papers by Pratima Chowdary Breakdown of academic impact, for papers by Martin R. Schipperus Breakdown of academic impact, for papers by Rudolf Pihusch
Rankless by CCL
2026